These cannabis ETFs deserve a look heading into 2022

361 0

Cannabis investments continue to move forward, and next year could provide improved returns

During this month, the cannabis sector declined to one of the lowest market values ever seen during the year, mainly due to delays with federal cannabis reform and the failure to promote any policies that would help the cannabis industry. While the news may sound bad, it actually opens up a great opportunity for investors to establish positions at lower price points. Exchange-traded funds (ETFs) have been gaining popularity. These are listed on major stock exchanges and offer investors in the cannabis space high exposure to the best marijuana stocks.

AdvisorShares Pure US Cannabis is undoubtedly one of the best-positioned ETFs on the market today. Aside from being the first marijuana ETF in the US, which gives it a great competitive advantage, this ETF exceeds $1 trillion in assets under management. Currently, this relevant marijuana ETF gives a priority focus to US cannabis companies as the most active and most invested.

Then, there is also Amplify Seymour Cannabis ETF, which offers investors great visibility and exposure to the global marijuana industry, with over 80% of its holdings in companies whose revenues are essentially based on hemp and cannabis production. With the arrival of huge companies in the US market, this ETF has established great relationships with Curaleaf Holdings, WM Technology, and Green Thumb Industries.

And finally, the Cannabis ETF is an Innovation Labs cannabis index that offers investors exponential exposure to global hemp, cannabis, and pharmaceutical-based CBD companies. It’s no secret that the medical sector in this industry is reaching huge peaks. Linking up with an ETF that opens the doors to this world can lead to great results.